Betterness

Betterness is an early-stage biotech company headquartered in Boston, Massachusetts, established in 2018 with a mission to address unmet needs in autoimmune and inflammatory conditions. The company is focused on discovering and developing novel therapeutic candidates, though specific pipeline programs and development stages have not been publicly disclosed. As a private, pre-revenue company, Betterness operates in a competitive landscape alongside other innovators targeting immunology and inflammation pathways.